These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1751122)

  • 1. Protamine-coated Cuprophan. A potential nonthrombogenic hemodialysis membrane with improved blood compatibility.
    Yang VC; Fu YY; Kim JS
    ASAIO Trans; 1991; 37(3):M229-32. PubMed ID: 1751122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A protamine filter for extracorporeal heparin removal. Development, testing, blood compatibility evaluation, and future direction.
    Byun Y; Yun JH; Han IS; Fu Y; Shanberge JN; Yang VC
    ASAIO J; 1995; 41(3):M301-5. PubMed ID: 8573812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protamine immobilization and heparin adsorption on the protamine-bound cellulose fiber membrane.
    Kim JS; Yang AJ; Yang VC
    Biotechnol Bioeng; 1992 Feb; 39(4):450-6. PubMed ID: 18600967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of protamine hollow-fiber device for extracorporeal heparin removal.
    Liang JF; Emregul E; Yang VC
    Blood Purif; 2004; 22(2):198-202. PubMed ID: 15044818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of heparinized Cuprophan hemodialysis membranes.
    Hinrichs WL; ten Hoopen HW; Engbers GH; Feijen J
    J Biomed Mater Res; 1997 Jun; 35(4):443-50. PubMed ID: 9189822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for improving the functionality of an affinity bioreactor.
    Wang T; Yang Z; Emregul E; David A; Balthasar JP; Liang J; Yang VC
    Int J Pharm; 2005 Dec; 306(1-2):132-41. PubMed ID: 16246511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protamine filter for extracorporeal blood heparin removal.
    Teng CL; Kim JS; Port FK; Wakefield TW; Till GO; Yang VC
    ASAIO Trans; 1988; 34(3):743-6. PubMed ID: 3196594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophan.
    Cheung AK; Parker CJ; Wilcox LA; Janatova J
    Kidney Int; 1990 Apr; 37(4):1055-9. PubMed ID: 2342244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation.
    Chang LC; Lee HF; Chung MJ; Yang VC
    Bioconjug Chem; 2005; 16(1):147-55. PubMed ID: 15656586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel approach to anticoagulation control.
    Kim JS; Vincent C; Teng CL; Wakefield TW; Yang VC
    ASAIO Trans; 1989; 35(3):644-6. PubMed ID: 2597555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood compatibility and permeability of heparin-modified polysulfone as potential membrane for simultaneous hemodialysis and LDL removal.
    Huang XJ; Guduru D; Xu ZK; Vienken J; Groth T
    Macromol Biosci; 2011 Jan; 11(1):131-40. PubMed ID: 20878965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct synthesis of heparin-like poly(ether sulfone) polymer and its blood compatibility.
    Wang LR; Qin H; Nie SQ; Sun SD; Ran F; Zhao CS
    Acta Biomater; 2013 Nov; 9(11):8851-63. PubMed ID: 23871943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of RBCs on the activation of human complement by heparin-protamine complexes.
    Shastri KA; Phillips MJ; Raza S; Logue GL; Rustagi PK
    Blood; 1988 Jan; 71(1):36-40. PubMed ID: 3334899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of complement activation with EDTA in vivo during sham hemodialysis.
    Kandus A; Benedik M; Bren AF; Drinovec J; Fliser D; Knap B; Kladnik S; Ivanovich P
    Int J Artif Organs; 1991 Aug; 14(8):515-7. PubMed ID: 1937941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialyzer membranes: effect of surface area and chemical modification of cellulose on complement and platelet activation.
    Mahiout A; Meinhold H; Kessel M; Schulze H; Baurmeister U
    Artif Organs; 1987 Apr; 11(2):149-54. PubMed ID: 3036050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the complement C3 fragments associated with hemodialysis membranes.
    Cheung AK; Parker CJ; Janatova J
    Kidney Int; 1989 Feb; 35(2):576-88. PubMed ID: 2785224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly-L-lysine amplification of protamine immobilization and heparin adsorption.
    Zhang Y; Singh VK; Yang VC
    J Biomed Mater Res; 1998 Nov; 42(2):182-7. PubMed ID: 9773814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adsorption of unactivated complement proteins by hemodialysis membranes.
    Cheung AK
    Am J Kidney Dis; 1989 Dec; 14(6):472-7. PubMed ID: 2596474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimodule dialyser for quantitative ex vivo evaluation of membrane haemocompatibility in humans: comparison of acrylonitrile copolymer, cuprophan and polysulphone hollow fibres.
    Mulvihill J; Cazenave JP; Mazzucotelli JP; Crost T; Collier C; Renaux JL; Pusineri C
    Biomaterials; 1992; 13(8):527-36. PubMed ID: 1633226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on dialyzers with improved biocompatibility.
    van der Steen A
    Clin Nephrol; 1986; 26 Suppl 1():S39-42. PubMed ID: 3829466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.